EXAS Financial Facts
Interest income: 535KNet loss per share-basic and diluted (in dollars per share): -0.36
See Full Income Statement
Less-Accumulated depreciation: -21.98M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 403.21M
See Full Balance Sheet
Exact Sciences (EXAS) Earnings
|
Expand Research on EXAS
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +252.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | -$0.18 | N/A | N/A | $836.38M | N/A | N/A | N/A | ||
| 2/24/26 |
Q425 | N/A | -$0.08 | N/A | N/A | $860.9M | = | N/A | N/A | ||
| 11/3/25 | Q325 | $0.24 | -$0.03 | +$0.27 | $851M | $810.36M | = |  | | Details | |
| 8/6/25 | Q225 | -$0.01 | -$0.13 | +$0.12 | $811.1M | $773.8M | = | | | Details | |
| 5/1/25 | Q125 | -$0.54 | -$0.33 | -$0.21 | $707M | $688.78M | = | | | Details | |
| 2/19/25 | Q424 | -$0.06 | -$0.33 | +$0.27 | $713.4M | $694.92M | = | | | Details | |
| 11/5/24 | Q324 | -$0.21 | -$0.20 | -$0.01 | $709M | $716.8M |  |
| | Details | |
| 7/31/24 | Q224 | -$0.09 | -$0.34 | +$0.25 | $699.26M | $690.01M | |
| | Details |
